Teva Pharma under investigation for U.S. anti-bribery law

By Admin
Teva Pharmaceutical Industries is being investigated by the U.S. securities regulator on violations of a U.S. anti-bribery law, the news reports said...

Teva Pharmaceutical Industries is being investigated by the U.S. securities regulator on violations of a U.S. anti-bribery law, the news reports said.

The global generic drug maker said in a filing with U.S. Securities and Exchange Commission that in July it has secured a subpoena from SEC regulator asking to produce documents pertaining to allegations on bribing officials in Latin America.  

The Tel-Aviv-based company said, “These matters are in their early stages and no conclusion can be drawn at this time as to any likely outcomes.”   It also said besides cooperating with US government on the probe, it has also hired an independent counsel to assist in its own internal investigation into its certain business practice in Latin America. 

Teva is the latest drug maker that has come under the scanner of the U.S. regulators, who have since past three years conducting an investigation in the pharmaceutical industry practices of offering bribes to doctors in state-run hospitals to buy their brand of drugs, the reports said.  

Teva Pharmaceuticals is the global pharma company based in Israel. The company specializes in active pharmaceutical ingredients and in generic and proprietary pharmaceuticals. It is the largest generic drug maker having 15 largest pharmaceutical companies world over.

Share
Share

Featured Articles

Johnson & Johnson: Turning supplier spend into local support

Johnson & Johnson’s Global Supplier Diversity & Inclusion team is growing spending with social enterprises around the globe to expand its impact

Seasonal Affective Disorder’s impact on health & solutions

Dr Ravi Gill & Dr. Naomi Newman-Beinart discuss Seasonal Affective Disorder and its treatments, from vitamin D spray to light therapy

CGI teams up with Totalmobile for digital healthcare service

CGI is driving efficiency in healthcare. Hear from Helena Jochberger, at Manufacturing Digital LIVE, a free virtual event on Wednesday 6th December 2023

Deloitte: generative AI can improve access to healthcare

Technology & AI

Wipro & NVIDIA’s revolutionary healthcare uses generative AI

AI & ML

Healthtech platform CoverSelf extends seed round to US$8.2m

Technology & AI